Xiao WH - Search Results

1

[Thyrocytes contribute to their own demise: the role of interleukin-18 in Hashimoto's thyroiditis].

Xiao WH, Hong TP, Wang HN, Liu GQ, Liu Z, Wang YR. Xiao WH, et al. Zhonghua Yi Xue Za Zhi. 2008 Nov 4;88(40):2817-20. Zhonghua Yi Xue Za Zhi. 2008. PMID: 19080488 Chinese.

2

Thyrocyte interleukin-18 expression is up-regulated by interferon-γ and may contribute to thyroid destruction in Hashimoto's thyroiditis.

Liu Z, Wang H, Xiao W, Wang C, Liu G, Hong T. Liu Z, et al. Int J Exp Pathol. 2010 Oct;91(5):420-5. doi: 10.1111/j.1365-2613.2010.00715.x. Int J Exp Pathol. 2010. PMID: 20586818 Free PMC article.

3

[Efficacy and safety of extended-release metformin in treatment of type 2 diabetes mellitus].

Zhang JP, Yang WY, Hong TP, Yang JK, Xiao WH, Gao HW, Yang Y. Zhang JP, et al. Among authors: xiao wh. Zhonghua Yi Xue Za Zhi. 2007 May 15;87(18):1238-40. Zhonghua Yi Xue Za Zhi. 2007. PMID: 17686255 Clinical Trial. Chinese.

4

Effect of Levothyroxine on Miscarriage Among Women With Normal Thyroid Function and Thyroid Autoimmunity Undergoing In Vitro Fertilization and Embryo Transfer: A Randomized Clinical Trial.

Wang H, Gao H, Chi H, Zeng L, Xiao W, Wang Y, Li R, Liu P, Wang C, Tian Q, Zhou Z, Yang J, Liu Y, Wei R, Mol BWJ, Hong T, Qiao J. Wang H, et al. JAMA. 2017 Dec 12;318(22):2190-2198. doi: 10.1001/jama.2017.18249. JAMA. 2017. PMID: 29234808 Clinical Trial.

5

The effects of pioglitazone on biochemical markers of bone turnover in the patients with type 2 diabetes.

Xiao WH, Wang YR, Hou WF, Xie C, Wang HN, Hong TP, Gao HW. Xiao WH, et al. Int J Endocrinol. 2013;2013:290734. doi: 10.1155/2013/290734. Epub 2013 Jun 16. Int J Endocrinol. 2013. PMID: 23843787 Free PMC article.

6

GLP-1 receptor agonists stimulate ANGPTL8 production through the PI3K/Akt pathway in a GLP-1 receptor-dependent manner.

Liu J, Yang K, Xiao W, Le Y, Lang S, Zhang J, Wei R, Yang J, Hong T. Liu J, et al. Peptides. 2018 Aug;106:83-90. doi: 10.1016/j.peptides.2018.07.001. Epub 2018 Jul 9. Peptides. 2018. PMID: 30003931 Clinical Trial.

7

High baseline FGF21 levels are associated with poor glucose-lowering efficacy of exenatide in patients with type 2 diabetes.

Yang K, Wang H, Wei R, Xiao W, Tian Q, Wang C, Yang J, Hong T. Yang K, et al. Acta Diabetol. 2021 May;58(5):595-602. doi: 10.1007/s00592-020-01660-z. Epub 2021 Jan 15. Acta Diabetol. 2021. PMID: 33452595 Clinical Trial.

8

Liver-derived fibroblast growth factor 21 mediates effects of glucagon-like peptide-1 in attenuating hepatic glucose output.

Liu J, Yang K, Yang J, Xiao W, Le Y, Yu F, Gu L, Lang S, Tian Q, Jin T, Wei R, Hong T. Liu J, et al. EBioMedicine. 2019 Mar;41:73-84. doi: 10.1016/j.ebiom.2019.02.037. Epub 2019 Mar 1. EBioMedicine. 2019. PMID: 30827929 Free PMC article. Clinical Trial.

9

Diabetes, even newly defined by HbA1c testing, is associated with an increased risk of in-hospital death in adults with COVID-19.

Liu Y, Lu R, Wang J, Cheng Q, Zhang R, Zhang S, Le Y, Wang H, Xiao W, Gao H, Zeng L, Hong T. Liu Y, et al. BMC Endocr Disord. 2021 Mar 26;21(1):56. doi: 10.1186/s12902-021-00717-6. BMC Endocr Disord. 2021. PMID: 33771154 Free PMC article.

10

Association of Time in Range with Endothelial Injury in Patients with Type 2 Diabetes Treated with Exenatide.

Le Y, Yang K, Yang J, Fu W, Xiao W, Wei R, Hong T. Le Y, et al. Diabetes Ther. 2022 Oct;13(10):1755-1767. doi: 10.1007/s13300-022-01310-3. Epub 2022 Aug 13. Diabetes Ther. 2022. PMID: 35963931 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

135 results

Search Page

Filters